RBC Capital upgrades Iberdrola (OTC:IBDRY) from Underperform to Sector Perform.
Adamis Pharma Offers Update On Clinical Trial Start-Up Progress For Tempol In Treatment Of COVID-19
Activities Proceeding for Phase 2/3 Trial Examining the Effects of Tempol for the Treatment of COVID-19
SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced